GK PHARMA ApS — Credit Rating and Financial Key Figures
CVR number: 81267316
Egøjevej 162 C, 4600 Køge
tel: 56217276
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 | 12 |
Net sales | 13 992.64 | ||||
Costs of manufacturing | -9 432.70 | ||||
Gross profit | 4 559.94 | 4 244.23 | 3 925.63 | 3 213.56 | 3 822.56 |
Costs of management | -2 680.10 | -2 135.06 | -2 446.72 | -1 893.22 | -2 291.98 |
Costs of distribution | -40.45 | -43.04 | -1.53 | -83.70 | - 192.90 |
EBIT | 1 839.39 | 2 066.13 | 1 480.44 | 1 236.63 | 1 337.67 |
Other financial income | 30.83 | 21.31 | 189.77 | 203.00 | |
Other financial expenses | -51.88 | -88.82 | - 185.72 | - 297.52 | - 307.94 |
Pre-tax profit | 1 787.51 | 2 008.15 | 1 316.04 | 1 128.88 | 1 232.73 |
Income taxes | - 402.71 | - 445.59 | - 309.50 | - 267.04 | - 278.49 |
Net earnings | 1 384.80 | 1 562.56 | 1 006.53 | 861.84 | 954.24 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Intangible assets total | |||||
Buildings | 195.69 | 999.25 | |||
Tangible assets total | 195.69 | 999.25 | |||
Investments total | 180.00 | 180.00 | 180.00 | 180.00 | |
Non-current other receivables | 180.00 | ||||
Long term receivables total | 180.00 | ||||
Raw materials and consumables | 1 800.66 | 1 847.09 | 1 758.07 | 1 826.82 | |
Finished products/goods | 1 845.92 | 5.26 | 1.79 | 24.41 | 3.53 |
Inventories total | 1 845.92 | 1 805.92 | 1 848.88 | 1 782.47 | 1 830.35 |
Current trade debtors | 2 386.06 | 2 525.73 | 3 749.38 | 3 723.27 | 2 238.40 |
Current amounts owed by group member comp. | 4 164.00 | 4 356.27 | 3 726.11 | ||
Prepayments and accrued income | 586.88 | 86.74 | 20.24 | 0.00 | |
Current other receivables | 271.06 | 4.70 | 32.86 | 31.85 | |
Current deferred tax assets | 70.30 | 62.73 | 30.30 | ||
Short term receivables total | 3 244.00 | 2 612.47 | 8 008.62 | 8 175.13 | 6 026.66 |
Cash and bank deposits | 783.38 | 183.90 | 432.20 | 578.61 | |
Cash and cash equivalents | 783.38 | 183.90 | 432.20 | 578.61 | |
Balance sheet total (assets) | 6 053.30 | 4 782.28 | 10 469.71 | 10 333.30 | 9 614.88 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Share capital | 200.00 | 200.00 | 200.00 | 200.00 | 200.00 |
Shares repurchased | 1 384.80 | 1 503.03 | 850.00 | ||
Other reserves | - 850.00 | ||||
Retained earnings | -1 384.80 | -1 503.03 | 59.53 | 1 066.06 | 1 077.91 |
Profit of the financial year | 1 384.80 | 1 562.56 | 1 006.53 | 861.84 | 954.24 |
Shareholders equity total | 1 584.80 | 1 762.56 | 1 266.06 | 2 127.91 | 2 232.15 |
Non-current loans from credit institutions | 1 982.78 | 1 613.96 | 1 242.99 | ||
Non-current liabilities total | 1 982.78 | 1 613.96 | 1 242.99 | ||
Current loans from credit institutions | 0.88 | 2 297.62 | 817.45 | 473.31 | |
Current trade creditors | 823.35 | 833.17 | 958.32 | 1 721.69 | 1 641.78 |
Current owed to group member | 659.94 | ||||
Short-term deferred tax liabilities | 393.25 | 445.59 | 360.64 | 243.62 | 246.06 |
Other non-interest bearing current liabilities | 2 295.14 | 1 740.96 | 3 604.29 | 3 808.67 | 3 778.60 |
Accruals and deferred income | 295.95 | ||||
Current liabilities total | 4 468.51 | 3 019.72 | 7 220.87 | 6 591.43 | 6 139.74 |
Balance sheet total (liabilities) | 6 053.30 | 4 782.28 | 10 469.71 | 10 333.30 | 9 614.88 |
CreditReports API
- Company information
- Financial data
- Credit risk data
- All 400,000+ Danish companies
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions

... and more!
No registration needed.